NO20054723L - Behandling av proliferative sykdommer med epofilonderivater og straling - Google Patents

Behandling av proliferative sykdommer med epofilonderivater og straling

Info

Publication number
NO20054723L
NO20054723L NO20054723A NO20054723A NO20054723L NO 20054723 L NO20054723 L NO 20054723L NO 20054723 A NO20054723 A NO 20054723A NO 20054723 A NO20054723 A NO 20054723A NO 20054723 L NO20054723 L NO 20054723L
Authority
NO
Norway
Prior art keywords
treatment
radiation
epophilone
derivatives
proliferative diseases
Prior art date
Application number
NO20054723A
Other languages
English (en)
Inventor
Martin Pruschy
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of NO20054723L publication Critical patent/NO20054723L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Radiation-Therapy Devices (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Denne oppfinnelsen vedrører organiske forbindelser med formel (I) i særdeleshet farmasøytiske sammensetninger for anvendelse i kombinasjon med ioniserende sfråling for forsinkelse av progresjon eller behandling av en proliferativ sykdom, spesielt en sohd tumor.
NO20054723A 2003-03-14 2005-10-13 Behandling av proliferative sykdommer med epofilonderivater og straling NO20054723L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0305928.4A GB0305928D0 (en) 2003-03-14 2003-03-14 Organic compounds
PCT/EP2004/002610 WO2004080458A1 (en) 2003-03-14 2004-03-12 Treatment of proliferative diseases with epothilone derivatives and radiation

Publications (1)

Publication Number Publication Date
NO20054723L true NO20054723L (no) 2005-10-13

Family

ID=9954825

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20054723A NO20054723L (no) 2003-03-14 2005-10-13 Behandling av proliferative sykdommer med epofilonderivater og straling

Country Status (26)

Country Link
US (2) US20070129411A1 (no)
EP (1) EP1605937B1 (no)
JP (1) JP4927530B2 (no)
KR (1) KR20050109988A (no)
CN (2) CN101804050A (no)
AT (1) ATE491450T1 (no)
AU (1) AU2004218927A1 (no)
BR (1) BRPI0408366A (no)
CA (1) CA2519037A1 (no)
DE (1) DE602004030545D1 (no)
ES (1) ES2358109T3 (no)
GB (1) GB0305928D0 (no)
HK (1) HK1086493A1 (no)
IL (1) IL170632A (no)
IS (1) IS8059A (no)
MA (1) MA27634A1 (no)
MX (1) MXPA05009808A (no)
NO (1) NO20054723L (no)
NZ (1) NZ542305A (no)
PL (1) PL1605937T3 (no)
PT (1) PT1605937E (no)
RU (1) RU2381799C2 (no)
TN (1) TNSN05226A1 (no)
TW (1) TWI358295B (no)
WO (1) WO2004080458A1 (no)
ZA (1) ZA200506942B (no)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7649006B2 (en) 2002-08-23 2010-01-19 Sloan-Kettering Institute For Cancer Research Synthesis of epothilones, intermediates thereto and analogues thereof
ATE350383T1 (de) 2002-08-23 2007-01-15 Sloan Kettering Inst Cancer Synthese von epothilonen, zwischenprodukte dafür, analoga und deren verwendungen
EP1640004A1 (en) * 2004-09-24 2006-03-29 Schering Aktiengesellschaft Use of epothilones in the treatment of bone metastases and bone tumors or cancers
US20060121511A1 (en) 2004-11-30 2006-06-08 Hyerim Lee Biomarkers and methods for determining sensitivity to microtubule-stabilizing agents
EP3566719A1 (en) 2010-05-18 2019-11-13 Cerulean Pharma Inc. Compositions and methods for treatment of autoimmune and other diseases

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6441025B2 (en) * 1996-03-12 2002-08-27 Pg-Txl Company, L.P. Water soluble paclitaxel derivatives
CA2273083C (en) * 1996-12-03 2012-09-18 Sloan-Kettering Institute For Cancer Research Synthesis of epothilones, intermediates thereto, analogues and uses thereof
US6605599B1 (en) * 1997-07-08 2003-08-12 Bristol-Myers Squibb Company Epothilone derivatives
JP2001288097A (ja) * 2000-04-07 2001-10-16 Pg-Txl Co Lp 水溶性パクリタキセル誘導体
MXPA03006412A (es) * 2001-01-25 2003-10-15 Bristol Myers Squibb Co Metodos para administrar analogos de epotilona para tratamiento de cancer.
EP1383490B1 (en) * 2001-03-14 2012-04-25 Bristol-Myers Squibb Company Combination of an epothilone analog and chemotherapeutic agents for the treatment of proliferative diseases

Also Published As

Publication number Publication date
EP1605937A1 (en) 2005-12-21
ATE491450T1 (de) 2011-01-15
CN101804050A (zh) 2010-08-18
MA27634A1 (fr) 2005-11-01
PL1605937T3 (pl) 2011-05-31
US20070129411A1 (en) 2007-06-07
ES2358109T3 (es) 2011-05-05
EP1605937B1 (en) 2010-12-15
CA2519037A1 (en) 2004-03-23
IL170632A (en) 2012-01-31
NZ542305A (en) 2009-03-31
RU2005131723A (ru) 2007-08-20
BRPI0408366A (pt) 2006-03-21
WO2004080458A1 (en) 2004-09-23
DE602004030545D1 (de) 2011-01-27
HK1086493A1 (en) 2006-09-22
KR20050109988A (ko) 2005-11-22
IS8059A (is) 2005-10-04
ZA200506942B (en) 2006-07-26
TW200505444A (en) 2005-02-16
AU2004218927A1 (en) 2004-09-23
PT1605937E (pt) 2011-03-17
JP4927530B2 (ja) 2012-05-09
TNSN05226A1 (en) 2007-06-11
GB0305928D0 (en) 2003-04-23
CN1758908A (zh) 2006-04-12
TWI358295B (en) 2012-02-21
RU2381799C2 (ru) 2010-02-20
MXPA05009808A (es) 2005-10-26
US20120053559A1 (en) 2012-03-01
JP2006520353A (ja) 2006-09-07

Similar Documents

Publication Publication Date Title
IL260127B (en) mek inhibitors and methods of using them
NO20055894L (no) Fremgangsmater og blandinger for behandling av amyloidrelatertere sykdommer
EA200701930A1 (ru) Производные пиримидина для лечения гиперпролиферативных нарушений
BRPI0510177B8 (pt) composto, composição farmacêutica e uso do mesmo
CY2015003I1 (el) Φαρμακευτικες συνθεσεις για θεραπεια καρκινου
ATE411022T1 (de) Pyridylpyrrol-derivate als wirksame kinase-hemmer
TW200600087A (en) Methods and compositions for treating amyloid-related diseases
MXPA05009595A (es) Compuestos 7-amino-isoindolilo y sus usos farmaceuticos.
IL180979A (en) Isoindulin compounds and their use
IS8398A (is) Lyfjasamsetningar til að meðhöndla æxli
BR0312573A (pt) Derivados de fenil-[4-(3-fenil-1h-pirazol-4-il)-pirimidin-2-il]-amina
IS7691A (is) Lyfjasamsetningar til að meðhöndla æxli
ATE370139T1 (de) Pyrazolopyridin derivate als tgf beta hemmstoffe zur behandlung von krebs
DE50310516D1 (de) Fredericamycin-derivate
DE60206911D1 (de) Imidazol-2-carbonsäureamid derivate als raf-kinase-inhibitoren
DE602004020070D1 (de) Thienopyrimidin-derivate als kaliumkanal-inhibitoren
WO2007016338A3 (en) Use of chk2 kinase inhibitors for cancer treatment
NO20054723L (no) Behandling av proliferative sykdommer med epofilonderivater og straling
WO2007050655A3 (en) Combination of histone deacetylase inhibitors and radiation
DK1551850T3 (da) 2"-oxo-voruscharin og derivater deraf
UA96742C2 (en) Mek inhibitors and use thereof

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application